Evidence map›Paper›PMID 40155601›Full record

ArticleBlood cancer journal2025

Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.

Vinod Pullarkat, Keith W Pratz, Hartmut Döhner, Christian Recher, Michael J Thirman, Courtney D DiNardo, Pierre Fenaux, Andre C Schuh, Andrew H Wei, Arnaud Pigneux and 10 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Vinod PullarkatDepartment of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. vpullarkat@coh.org.ORCID http://orcid.org/0000-0001-9129-3424
Keith W PratzAbramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-1284-8266
Hartmut DöhnerDepartment of Internal Medicine III, Ulm University Hospital, Ulm, Germany.ORCID http://orcid.org/0000-0003-2116-5536
Christian RecherCentre Hospitalier Universitaire de Toulouse, Toulouse, France.ORCID http://orcid.org/0000-0002-3332-4525
Michael J ThirmanSection of Hematology/Oncology, Department of Medicine, The University of Chicago Medicine, Chicago, IL, USA.
Courtney D DiNardoMontefiore-Einstein Comprehensive Cancer Center, Bronx, NY, USA.ORCID http://orcid.org/0000-0001-9003-0390
Pierre FenauxHôpital St. Louis/Assistance Publique-Hôpitaux de Paris and Université de Paris, Paris, France.
Andre C SchuhDepartment of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Andrew H WeiPeter MacCallum Cancer Centre, Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research and University of Melbourne, Melbourne, VIC, Australia.
Arnaud PigneuxDepartment of Hematology, CHU de Bordeaux, Bordeaux, France.ORCID http://orcid.org/0000-0001-5479-0261
Jun-Ho JangDepartment of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Gunnar JuliussonDepartment of Hematology, Skåne University Hospital, Lund, Sweden.ORCID http://orcid.org/0000-0002-7911-7265
Yasushi MiyazakiDepartment of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
Dominik SelleslagAlgemeen Ziekenhuis Sint-Jan, Brugge, Belgium.
Martha L ArellanoDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA.
Chenglong LiuAbbVie Inc., North Chicago, IL, USA.
Jean A RidgewayAbbVie Inc., North Chicago, IL, USA.
Jalaja PotluriAbbVie Inc., North Chicago, IL, USA.
Jovita SchulerAbbVie Inc., North Chicago, IL, USA.
Marina KonoplevaMontefiore-Einstein Comprehensive Cancer Center, Bronx, NY, USA.ORCID http://orcid.org/0000-0002-9347-2212

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40155601
PMCPMC11953227

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.